SPDR® S&P Pharmaceuticals ETF (XPH) — Technical state
As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Pullback inside an uptrend stack — Trades -4.9% vs the 50-day and +1.3% vs the 200-day average, 15.7% below the 52-week high and +32% off the 52-week low. Computed from daily closes. (as of 2026-11-05)
- Trend: SPDR® S&P Pharmaceuticals ETF trades 4.9% below its 50-day and 1.3% above its 200-day moving average. (as of 2026-11-05)
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the XPH overview. Research diary readings, not advice.
Trades -4.9% vs the 50-day and +1.3% vs the 200-day average, 15.7% below the 52-week high and +32% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day-1.5%
- vs 50-day-4.9%
- vs 200-day+1.3%
- 52-week band15.7% off the high · +32% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed down through the 50-day 41 sessions ago
- Stochastic%K 23.7 · %D 64.5 · bear cross
Continue: the XPH chart & overview · the signal board
FAQ · from the current data · as of 2026-11-05
Quick answers
What is the current Closelooknet signal on XPH?
Pullback inside an uptrend stack — Trades -4.9% vs the 50-day and +1.3% vs the 200-day average, 15.7% below the 52-week high and +32% off the 52-week low. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is XPH above its 50-day and 200-day moving averages?
As of 2026-11-05, SPDR® S&P Pharmaceuticals ETF trades -4.9% below its 50-day and +1.3% above its 200-day average, with the 20-day -1.5% away.
How far is XPH from its 52-week high?
15.7% below the 52-week high and 32% above the 52-week low, as of 2026-11-05.